83 related articles for article (PubMed ID: 23688428)
1. Recombinant disintegrin domain of ADAM15 inhibits the proliferation and migration of Bel-7402 cells.
Hou Y; Chu M; Du FF; Lei JY; Chen Y; Zhu RY; Gong XH; Ma X; Jin J
Biochem Biophys Res Commun; 2013 Jun; 435(4):640-5. PubMed ID: 23688428
[TBL] [Abstract][Full Text] [Related]
2. Antitumor and anti-angiogenic activity of the recombinant human disintegrin domain of A disintegrin and metalloproteinase 15.
Hou Y; Chu M; Cai Y; Lei J; Chen Y; Zhu R; Gong X; Ma X; Jin J
Mol Med Rep; 2015 Aug; 12(2):2360-6. PubMed ID: 25891130
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15.
Lu D; Xie S; Sukkar MB; Lu X; Scully MF; Chung KF
Am J Respir Cell Mol Biol; 2007 Oct; 37(4):494-500. PubMed ID: 17575078
[TBL] [Abstract][Full Text] [Related]
4. Role of ADAM-9 disintegrin-cysteine-rich domains in human keratinocyte migration.
Zigrino P; Steiger J; Fox JW; Löffek S; Schild A; Nischt R; Mauch C
J Biol Chem; 2007 Oct; 282(42):30785-93. PubMed ID: 17704059
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions.
Cominetti MR; Martin AC; Ribeiro JU; Djaafri I; Fauvel-Lafève F; Crépin M; Selistre-de-Araujo HS
Biochimie; 2009 Aug; 91(8):1045-52. PubMed ID: 19505527
[TBL] [Abstract][Full Text] [Related]
6. [Improving production and bioactivity of recombinant human disintegrin domain of ADAM15 (rhADAM15) in Escherichia coli].
Wu J; Lei J; Zhang L; Hua H; Jin J
Wei Sheng Wu Xue Bao; 2008 Aug; 48(8):1067-74. PubMed ID: 18956757
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of recombinant human ADAM15 disintegrin domain expression level by releasing the rare codons and amino acids restriction.
Wu J; Zhang L; Lei J; Cai G; Zhu W; Lu D; Jin J
Appl Biochem Biotechnol; 2009 May; 157(2):299-310. PubMed ID: 18679595
[TBL] [Abstract][Full Text] [Related]
8. Screening cellular proteins involved in the anti-proliferative effect of the ADAM15 disintegrin domain in murine melanoma cells.
Wu J; Zhang L; Ma X; Zhang X; Jin J
Oncol Rep; 2008 Sep; 20(3):669-75. PubMed ID: 18695922
[TBL] [Abstract][Full Text] [Related]
9. Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes.
Lee HD; Koo BH; Kim YH; Jeon OH; Kim DS
FASEB J; 2012 Jul; 26(7):3084-95. PubMed ID: 22505472
[TBL] [Abstract][Full Text] [Related]
10. Presence, processing, and localization of mouse ADAM15 during sperm maturation and the role of its disintegrin domain during sperm-egg binding.
Pastén-Hidalgo K; Hernández-Rivas R; Roa-Espitia AL; Sánchez-Gutiérrez M; Martínez-Pérez F; Monrroy AO; Hernández-González EO; Mújica A
Reproduction; 2008 Jul; 136(1):41-51. PubMed ID: 18390692
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15.
Daugimont L; Vandermeulen G; Defresne F; Bouzin C; Mir LM; Bouquet C; Feron O; Préat V
Eur J Pharm Biopharm; 2011 Aug; 78(3):314-9. PubMed ID: 21316447
[TBL] [Abstract][Full Text] [Related]
12. The role of the disintegrin metalloproteinase ADAM15 in prostate cancer progression.
Lucas N; Day ML
J Cell Biochem; 2009 Apr; 106(6):967-74. PubMed ID: 19229865
[TBL] [Abstract][Full Text] [Related]
13. Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation.
Jeon OH; Kim D; Choi YJ; Kim SH; Choi WS; Kim DS
Thromb Res; 2007; 119(5):609-19. PubMed ID: 16797059
[TBL] [Abstract][Full Text] [Related]
14. Recombinant disintegrin domain of human ADAM9 inhibits migration and invasion of DU145 prostate tumor cells.
Martin AC; Cardoso AC; Selistre-de-Araujo HS; Cominetti MR
Cell Adh Migr; 2015; 9(4):293-9. PubMed ID: 26211476
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of six aspartate (D) recombinant mojastin mutants (r-Moj): A second aspartate amino acid carboxyl to the RGD in r-Moj-D_ peptides is not sufficient to induce apoptosis of SK-Mel-28 cells.
Ramos CJ; Gutierrez DA; Aranda AS; Koshlaychuk MA; Carrillo DA; Medrano R; McBride TD; U A; Medina SM; Lombardo MC; Lucena SE; Sanchez EE; Soto JG
Toxicon; 2016 Aug; 118():36-42. PubMed ID: 27105671
[TBL] [Abstract][Full Text] [Related]
16. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin.
Trochon-Joseph V; Martel-Renoir D; Mir LM; Thomaïdis A; Opolon P; Connault E; Li H; Grenet C; Fauvel-Lafève F; Soria J; Legrand C; Soria C; Perricaudet M; Lu H
Cancer Res; 2004 Mar; 64(6):2062-9. PubMed ID: 15026344
[TBL] [Abstract][Full Text] [Related]
17. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta.
Wei P; Zhao YG; Zhuang L; Ruben S; Sang QX
Biochem Biophys Res Commun; 2001 Jan; 280(3):744-55. PubMed ID: 11162584
[TBL] [Abstract][Full Text] [Related]
18. Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-Mel-28.
Carey CM; Bueno R; Gutierrez DA; Petro C; Lucena SE; Sanchez EE; Soto JG
Toxicon; 2012 Feb; 59(2):241-8. PubMed ID: 22192732
[TBL] [Abstract][Full Text] [Related]
19. ADAM-15 disintegrin-like domain structure and function.
Lu D; Scully M; Kakkar V; Lu X
Toxins (Basel); 2010 Oct; 2(10):2411-27. PubMed ID: 22069559
[TBL] [Abstract][Full Text] [Related]
20. ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer.
Lorenzatti Hiles G; Bucheit A; Rubin JR; Hayward A; Cates AL; Day KC; El-Sawy L; Kunju LP; Daignault S; Lee CT; Liebert M; Hussain M; Day ML
PLoS One; 2016; 11(3):e0150138. PubMed ID: 26930657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
